FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34694911000001108: Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Aug 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104880001000001116 Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104880101000001115 Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Is a Proguanil 100mg / Atovaquone 250mg tablets 24 tablet true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Has AMP Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Has specific active ingredient Atovaquone true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Has specific active ingredient Proguanil hydrochloride true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) 24 tablet 2 x 12 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start